Covid-19 Impact on Preclinical CRO Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Preclinical CRO, including the following market information:
Major competitors identified in this market include Envigo Corporation, MPI research, Eurofins Scientific, PRA Health Sciences, Inc, Wuxi AppTec, Medpace, Inc., Pharmaceutical Product Development (PPD), LLC, PARAXEL International Corporation, ICON Plc., Laboratory Corporation of America, Inc., etc.
Based on the Region:
- Global Preclinical CRO Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Preclinical CRO Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Preclinical CRO Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Preclinical CRO Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Envigo Corporation, MPI research, Eurofins Scientific, PRA Health Sciences, Inc, Wuxi AppTec, Medpace, Inc., Pharmaceutical Product Development (PPD), LLC, PARAXEL International Corporation, ICON Plc., Laboratory Corporation of America, Inc., etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Bioanalysis & DMPK Studies
- Toxicology Testing
- Other Preclinical Services
- Biopharmaceutical Companies
- Government and Academic Institutes
- Medical Device Companies
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Preclinical CRO Industry
1.7 COVID-19 Impact: Preclinical CRO Market Trends
2 GLOBAL PRECLINICAL CRO QUARTERLY MARKET SIZE ANALYSIS
2.1 Preclinical CRO Business Impact Assessment - COVID-19
2.1.1 Global Preclinical CRO Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Preclinical CRO Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Preclinical CRO Quarterly Market Size, 2019 VS 2020
3.2 By Players, Preclinical CRO Headquarters and Area Served
3.3 Date of Key Players Enter into Preclinical CRO Market
3.4 Key Players Preclinical CRO Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON PRECLINICAL CRO SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Bioanalysis & DMPK Studies
1.4.2 Toxicology Testing
1.4.3 Other Preclinical Services
4.2 By Type, Global Preclinical CRO Market Size, 2019-2021
5 IMPACT OF COVID-19 ON PRECLINICAL CRO SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Biopharmaceutical Companies
5.5.2 Government and Academic Institutes
5.5.3 Medical Device Companies
5.2 By Application, Global Preclinical CRO Market Size, 2019-2021
5.2.1 By Application, Global Preclinical CRO Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Envigo Corporation
7.1.1 Envigo Corporation Business Overview
7.1.2 Envigo Corporation Preclinical CRO Quarterly Revenue, 2020
7.1.3 Envigo Corporation Preclinical CRO Product Introduction
7.1.4 Envigo Corporation Response to COVID-19 and Related Developments
7.2 MPI research
7.2.1 MPI research Business Overview
7.2.2 MPI research Preclinical CRO Quarterly Revenue, 2020
7.2.3 MPI research Preclinical CRO Product Introduction
7.2.4 MPI research Response to COVID-19 and Related Developments
7.3 Eurofins Scientific
7.3.1 Eurofins Scientific Business Overview
7.3.2 Eurofins Scientific Preclinical CRO Quarterly Revenue, 2020
7.3.3 Eurofins Scientific Preclinical CRO Product Introduction
7.3.4 Eurofins Scientific Response to COVID-19 and Related Developments
7.4 PRA Health Sciences, Inc
7.4.1 PRA Health Sciences, Inc Business Overview
7.4.2 PRA Health Sciences, Inc Preclinical CRO Quarterly Revenue, 2020
7.4.3 PRA Health Sciences, Inc Preclinical CRO Product Introduction
7.4.4 PRA Health Sciences, Inc Response to COVID-19 and Related Developments
7.5 Wuxi AppTec
7.5.1 Wuxi AppTec Business Overview
7.5.2 Wuxi AppTec Preclinical CRO Quarterly Revenue, 2020
7.5.3 Wuxi AppTec Preclinical CRO Product Introduction
7.5.4 Wuxi AppTec Response to COVID-19 and Related Developments
7.6 Medpace, Inc.
7.6.1 Medpace, Inc. Business Overview
7.6.2 Medpace, Inc. Preclinical CRO Quarterly Revenue, 2020
7.6.3 Medpace, Inc. Preclinical CRO Product Introduction
7.6.4 Medpace, Inc. Response to COVID-19 and Related Developments
7.7 Pharmaceutical Product Development (PPD), LLC
7.7.1 Pharmaceutical Product Development (PPD), LLC Business Overview
7.7.2 Pharmaceutical Product Development (PPD), LLC Preclinical CRO Quarterly Revenue, 2020
7.7.3 Pharmaceutical Product Development (PPD), LLC Preclinical CRO Product Introduction
7.7.4 Pharmaceutical Product Development (PPD), LLC Response to COVID-19 and Related Developments
7.8 PARAXEL International Corporation
7.8.1 PARAXEL International Corporation Business Overview
7.8.2 PARAXEL International Corporation Preclinical CRO Quarterly Revenue, 2020
7.8.3 PARAXEL International Corporation Preclinical CRO Product Introduction
7.8.4 PARAXEL International Corporation Response to COVID-19 and Related Developments
7.9 ICON Plc.
7.9.1 ICON Plc. Business Overview
7.9.2 ICON Plc. Preclinical CRO Quarterly Revenue, 2020
7.9.3 ICON Plc. Preclinical CRO Product Introduction
7.9.4 ICON Plc. Response to COVID-19 and Related Developments
7.10 Laboratory Corporation of America, Inc.
7.10.1 Laboratory Corporation of America, Inc. Business Overview
7.10.2 Laboratory Corporation of America, Inc. Preclinical CRO Quarterly Revenue, 2020
7.10.3 Laboratory Corporation of America, Inc. Preclinical CRO Product Introduction
7.10.4 Laboratory Corporation of America, Inc. Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Preclinical CRO Industry
1.7 COVID-19 Impact: Preclinical CRO Market Trends
2 GLOBAL PRECLINICAL CRO QUARTERLY MARKET SIZE ANALYSIS
2.1 Preclinical CRO Business Impact Assessment - COVID-19
2.1.1 Global Preclinical CRO Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Preclinical CRO Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Preclinical CRO Quarterly Market Size, 2019 VS 2020
3.2 By Players, Preclinical CRO Headquarters and Area Served
3.3 Date of Key Players Enter into Preclinical CRO Market
3.4 Key Players Preclinical CRO Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON PRECLINICAL CRO SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Bioanalysis & DMPK Studies
1.4.2 Toxicology Testing
1.4.3 Other Preclinical Services
4.2 By Type, Global Preclinical CRO Market Size, 2019-2021
5 IMPACT OF COVID-19 ON PRECLINICAL CRO SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Biopharmaceutical Companies
5.5.2 Government and Academic Institutes
5.5.3 Medical Device Companies
5.2 By Application, Global Preclinical CRO Market Size, 2019-2021
5.2.1 By Application, Global Preclinical CRO Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Envigo Corporation
7.1.1 Envigo Corporation Business Overview
7.1.2 Envigo Corporation Preclinical CRO Quarterly Revenue, 2020
7.1.3 Envigo Corporation Preclinical CRO Product Introduction
7.1.4 Envigo Corporation Response to COVID-19 and Related Developments
7.2 MPI research
7.2.1 MPI research Business Overview
7.2.2 MPI research Preclinical CRO Quarterly Revenue, 2020
7.2.3 MPI research Preclinical CRO Product Introduction
7.2.4 MPI research Response to COVID-19 and Related Developments
7.3 Eurofins Scientific
7.3.1 Eurofins Scientific Business Overview
7.3.2 Eurofins Scientific Preclinical CRO Quarterly Revenue, 2020
7.3.3 Eurofins Scientific Preclinical CRO Product Introduction
7.3.4 Eurofins Scientific Response to COVID-19 and Related Developments
7.4 PRA Health Sciences, Inc
7.4.1 PRA Health Sciences, Inc Business Overview
7.4.2 PRA Health Sciences, Inc Preclinical CRO Quarterly Revenue, 2020
7.4.3 PRA Health Sciences, Inc Preclinical CRO Product Introduction
7.4.4 PRA Health Sciences, Inc Response to COVID-19 and Related Developments
7.5 Wuxi AppTec
7.5.1 Wuxi AppTec Business Overview
7.5.2 Wuxi AppTec Preclinical CRO Quarterly Revenue, 2020
7.5.3 Wuxi AppTec Preclinical CRO Product Introduction
7.5.4 Wuxi AppTec Response to COVID-19 and Related Developments
7.6 Medpace, Inc.
7.6.1 Medpace, Inc. Business Overview
7.6.2 Medpace, Inc. Preclinical CRO Quarterly Revenue, 2020
7.6.3 Medpace, Inc. Preclinical CRO Product Introduction
7.6.4 Medpace, Inc. Response to COVID-19 and Related Developments
7.7 Pharmaceutical Product Development (PPD), LLC
7.7.1 Pharmaceutical Product Development (PPD), LLC Business Overview
7.7.2 Pharmaceutical Product Development (PPD), LLC Preclinical CRO Quarterly Revenue, 2020
7.7.3 Pharmaceutical Product Development (PPD), LLC Preclinical CRO Product Introduction
7.7.4 Pharmaceutical Product Development (PPD), LLC Response to COVID-19 and Related Developments
7.8 PARAXEL International Corporation
7.8.1 PARAXEL International Corporation Business Overview
7.8.2 PARAXEL International Corporation Preclinical CRO Quarterly Revenue, 2020
7.8.3 PARAXEL International Corporation Preclinical CRO Product Introduction
7.8.4 PARAXEL International Corporation Response to COVID-19 and Related Developments
7.9 ICON Plc.
7.9.1 ICON Plc. Business Overview
7.9.2 ICON Plc. Preclinical CRO Quarterly Revenue, 2020
7.9.3 ICON Plc. Preclinical CRO Product Introduction
7.9.4 ICON Plc. Response to COVID-19 and Related Developments
7.10 Laboratory Corporation of America, Inc.
7.10.1 Laboratory Corporation of America, Inc. Business Overview
7.10.2 Laboratory Corporation of America, Inc. Preclinical CRO Quarterly Revenue, 2020
7.10.3 Laboratory Corporation of America, Inc. Preclinical CRO Product Introduction
7.10.4 Laboratory Corporation of America, Inc. Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Preclinical CRO Assessment
Table 9. COVID-19 Impact: Preclinical CRO Market Trends
Table 10. COVID-19 Impact Global Preclinical CRO Market Size
Table 11. Global Preclinical CRO Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Preclinical CRO Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Preclinical CRO Market Growth Drivers
Table 14. Global Preclinical CRO Market Restraints
Table 15. Global Preclinical CRO Market Opportunities
Table 16. Global Preclinical CRO Market Challenges
Table 17. By Players, Preclinical CRO Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Preclinical CRO Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Preclinical CRO Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Preclinical CRO Market
Table 21. Key Players Preclinical CRO Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Preclinical CRO Market Size 2019-2021, (US$ Million)
Table 24. Global Preclinical CRO Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Preclinical CRO Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 57. Envigo Corporation Business Overview
Table 58. Envigo Corporation Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Envigo Corporation Preclinical CRO Product
Table 60. Envigo Corporation Response to COVID-19 and Related Developments
Table 61. MPI research Business Overview
Table 62. MPI research Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. MPI research Preclinical CRO Product
Table 64. MPI research Response to COVID-19 and Related Developments
Table 65. Eurofins Scientific Business Overview
Table 66. Eurofins Scientific Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Eurofins Scientific Preclinical CRO Product
Table 68. Eurofins Scientific Response to COVID-19 and Related Developments
Table 69. PRA Health Sciences, Inc Business Overview
Table 70. PRA Health Sciences, Inc Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. PRA Health Sciences, Inc Preclinical CRO Product
Table 72. PRA Health Sciences, Inc Response to COVID-19 and Related Developments
Table 73. Wuxi AppTec Business Overview
Table 74. Wuxi AppTec Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Wuxi AppTec Preclinical CRO Product
Table 76. Wuxi AppTec Response to COVID-19 and Related Developments
Table 77. Medpace, Inc. Business Overview
Table 78. Medpace, Inc. Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Medpace, Inc. Preclinical CRO Product
Table 80. Medpace, Inc. Response to COVID-19 and Related Developments
Table 81. Pharmaceutical Product Development (PPD), LLC Business Overview
Table 82. Pharmaceutical Product Development (PPD), LLC Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Pharmaceutical Product Development (PPD), LLC Preclinical CRO Product
Table 84. Pharmaceutical Product Development (PPD), LLC Response to COVID-19 and Related Developments
Table 85. PARAXEL International Corporation Business Overview
Table 86. PARAXEL International Corporation Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. PARAXEL International Corporation Preclinical CRO Product
Table 88. PARAXEL International Corporation Response to COVID-19 and Related Developments
Table 89. ICON Plc. Business Overview
Table 90. ICON Plc. Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. ICON Plc. Preclinical CRO Product
Table 92. ICON Plc. Response to COVID-19 and Related Developments
Table 93. Laboratory Corporation of America, Inc. Business Overview
Table 94. Laboratory Corporation of America, Inc. Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Laboratory Corporation of America, Inc. Preclinical CRO Product
Table 96. Laboratory Corporation of America, Inc. Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Preclinical CRO Assessment
Table 9. COVID-19 Impact: Preclinical CRO Market Trends
Table 10. COVID-19 Impact Global Preclinical CRO Market Size
Table 11. Global Preclinical CRO Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Preclinical CRO Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Preclinical CRO Market Growth Drivers
Table 14. Global Preclinical CRO Market Restraints
Table 15. Global Preclinical CRO Market Opportunities
Table 16. Global Preclinical CRO Market Challenges
Table 17. By Players, Preclinical CRO Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Preclinical CRO Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Preclinical CRO Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Preclinical CRO Market
Table 21. Key Players Preclinical CRO Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Preclinical CRO Market Size 2019-2021, (US$ Million)
Table 24. Global Preclinical CRO Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Preclinical CRO Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Preclinical CRO Market Size, 2019-2021 (US$ Million)
Table 57. Envigo Corporation Business Overview
Table 58. Envigo Corporation Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Envigo Corporation Preclinical CRO Product
Table 60. Envigo Corporation Response to COVID-19 and Related Developments
Table 61. MPI research Business Overview
Table 62. MPI research Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. MPI research Preclinical CRO Product
Table 64. MPI research Response to COVID-19 and Related Developments
Table 65. Eurofins Scientific Business Overview
Table 66. Eurofins Scientific Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Eurofins Scientific Preclinical CRO Product
Table 68. Eurofins Scientific Response to COVID-19 and Related Developments
Table 69. PRA Health Sciences, Inc Business Overview
Table 70. PRA Health Sciences, Inc Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. PRA Health Sciences, Inc Preclinical CRO Product
Table 72. PRA Health Sciences, Inc Response to COVID-19 and Related Developments
Table 73. Wuxi AppTec Business Overview
Table 74. Wuxi AppTec Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Wuxi AppTec Preclinical CRO Product
Table 76. Wuxi AppTec Response to COVID-19 and Related Developments
Table 77. Medpace, Inc. Business Overview
Table 78. Medpace, Inc. Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Medpace, Inc. Preclinical CRO Product
Table 80. Medpace, Inc. Response to COVID-19 and Related Developments
Table 81. Pharmaceutical Product Development (PPD), LLC Business Overview
Table 82. Pharmaceutical Product Development (PPD), LLC Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Pharmaceutical Product Development (PPD), LLC Preclinical CRO Product
Table 84. Pharmaceutical Product Development (PPD), LLC Response to COVID-19 and Related Developments
Table 85. PARAXEL International Corporation Business Overview
Table 86. PARAXEL International Corporation Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. PARAXEL International Corporation Preclinical CRO Product
Table 88. PARAXEL International Corporation Response to COVID-19 and Related Developments
Table 89. ICON Plc. Business Overview
Table 90. ICON Plc. Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. ICON Plc. Preclinical CRO Product
Table 92. ICON Plc. Response to COVID-19 and Related Developments
Table 93. Laboratory Corporation of America, Inc. Business Overview
Table 94. Laboratory Corporation of America, Inc. Preclinical CRO Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Laboratory Corporation of America, Inc. Preclinical CRO Product
Table 96. Laboratory Corporation of America, Inc. Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Preclinical CRO Product Picture
Figure 2. Preclinical CRO Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Preclinical CRO Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Preclinical CRO Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Preclinical CRO Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Preclinical CRO Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Preclinical CRO Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Preclinical CRO Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Preclinical CRO Market Size Market Share, 2019-2021
Figure 1. Preclinical CRO Product Picture
Figure 2. Preclinical CRO Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Preclinical CRO Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Preclinical CRO Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Preclinical CRO Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Preclinical CRO Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Preclinical CRO Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Preclinical CRO Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Preclinical CRO Market Size Market Share, 2019-2021
